Clinical Trials Directory

Trials / Unknown

UnknownNCT03330626

VolumE maNagement Under Body Composition Monitoring in Critically Ill patientS on CRRT

VolumE maNagement Under Body Composition Monitoring in Critically Ill patientS on CRRT; Randomized-controlled Trial (VENUS Trial)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
244 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Although monitoring fluid balance for continuous renal replacement therapy-treated patients is an important issue, most physicians usually use conventional methods such as the difference between the amount of intake and output (I \& O), which is not objective way. Meanwhile, bioimpedance electrical vector analysis presents the patients' fluid status with more objective data. Thus, the investigators will investigate the clinical benefit for monitoring fluid balance when the investigators use InBody S10, one of representative bioimpedance electrical vector analysis, compared with conventional methods among the patients who need continuous renal replacement therapy.

Detailed description

Although monitoring fluid balance for continuous renal replacement therapy-treated patients is an important issue, most physicians usually use conventional methods such as the difference between the amount of intake and output (I \& O), which is not objective way. Meanwhile, bioimpedance electrical vector analysis presents the patients' fluid status with more objective data. Thus, the investigators will investigate the clinical benefit for monitoring fluid balance by using InBody S10 (0, 1, 2-day, and 7-day from CRRT initiation), one of representative bioimpedance electrical vector analysis, compared with conventional methods among the patients who need continuous renal replacement therapy.

Conditions

Interventions

TypeNameDescription
DEVICEInBody groupAs one of representative BIVA, it provides the patients' fluid status with more objective data such as TBW, ECW, ICW, etc.
OTHERIO groupFluid removal are guided by intake-output balance.

Timeline

Start date
2017-07-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2017-11-06
Last updated
2017-11-06

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03330626. Inclusion in this directory is not an endorsement.